Schisandrin B attenuates renal fibrosis via miR-30e-mediated inhibition of EMT.

This study shows that miR-30e can serve as a therapeutic target in the treatment of patients with TIF and that Sch B may potentially be used in therapy against renal fibrosis.
PMID: 31697999 [PubMed - as supplied by publisher]

Source: Toxicology and Applied Pharmacology - November 3, 2019 Category: Toxicology Authors: Cao G, Li S, Shi H, Yin P, Chen J, Li H, Zhong Y, Diao LT, Du B Tags: Toxicol Appl Pharmacol Source Type: research